Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolyon P Mitchell

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
AAPS Pharmscitech|July 13, 2010
Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 2--investigation of bias in extra-fine mass fraction with AIM-HRT impactorJolyon P Mitchell, Mark W Nagel, Cathy C Doyle, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 4, 2022
Moving Forward from "Fine Particle Fraction: The Good and the Bad"Jolyon P Mitchell, William Doub, J David Christopher, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|October 24, 2003
Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: DesignVirgil A Marple, Daryl L Roberts, Francisco J Romay, et al.
AAPS Pharmscitech|March 3, 2023
Good Practices for the Laboratory Performance Testing of Aqueous Oral Inhaled Products (OIPs): an Assessment from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS)Jolyon P Mitchell, I Carter, J D Christopher, et al.
AAPS Pharmscitech|May 30, 2014
Investigation of dry powder inhaler (DPI) resistance and aerosol dispersion timing on emitted aerosol aerodynamic particle sizing by multistage cascade impactor when sampled volume is reduced from compendial value of 4 LHlack Mohammed, Jan Arp, Frank Chambers, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 27, 2020
Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking GroupJolyon P Mitchell, Ariel Berlinski, Sebastian Canisius, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
AAPS Pharmscitech|July 13, 2010
Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 2--investigation of bias in extra-fine mass fraction with AIM-HRT impactorJolyon P Mitchell, Mark W Nagel, Cathy C Doyle, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 4, 2022
Moving Forward from "Fine Particle Fraction: The Good and the Bad"Jolyon P Mitchell, William Doub, J David Christopher, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|October 24, 2003
Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: DesignVirgil A Marple, Daryl L Roberts, Francisco J Romay, et al.
AAPS Pharmscitech|March 3, 2023
Good Practices for the Laboratory Performance Testing of Aqueous Oral Inhaled Products (OIPs): an Assessment from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS)Jolyon P Mitchell, I Carter, J D Christopher, et al.
AAPS Pharmscitech|May 30, 2014
Investigation of dry powder inhaler (DPI) resistance and aerosol dispersion timing on emitted aerosol aerodynamic particle sizing by multistage cascade impactor when sampled volume is reduced from compendial value of 4 LHlack Mohammed, Jan Arp, Frank Chambers, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 27, 2020
Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking GroupJolyon P Mitchell, Ariel Berlinski, Sebastian Canisius, et al.
Pageof 6